SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-20-002303
Filing Date
2020-04-02
Accepted
2020-04-02 15:00:13
Documents
6
Period of Report
2020-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_040220.htm 8-K 48843
2 EXHIBIT 10.01 exh_1001.htm EX-10.01 110270
3 EXHIBIT 10.02 exh_1002.htm EX-10.02 112636
4 EXHIBIT 99.01 exh_9901.htm EX-99.01 59598
5 EXHIBIT 99.02 exh_9902.htm EX-99.02 10229
6 GRAPHIC logo.jpg GRAPHIC 2959
  Complete submission text file 0001171843-20-002303.txt   347375
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 20768550
SIC: 2836 Biological Products, (No Diagnostic Substances)